Why is Clinitech Lab falling/rising?

As of 12-Sep, Clinitech Laboratory Ltd's stock is currently priced at Rs 46.04, reflecting a decline of Rs 2.42 or 4.99%. The stock has been underperforming, having lost 15.52% over the last four days, and opened today with a loss of 4.99%. It has consistently traded at this price without any range, and its delivery volume has significantly decreased by 73.68% compared to the five-day average, indicating falling investor participation. Additionally, the stock's performance over various periods shows a year-to-date decline of 41.62% and a one-year decline of 42.56%, suggesting ongoing challenges for the company. There are no positive or negative factors available to further explain the stock's recent movement.
Broader Market Context: In comparison to the benchmark Sensex, Clinitech's stock has significantly underperformed, with a one-week return of -12.09% against the Sensex's gain of 1.48%. This stark contrast highlights the stock's struggles relative to the broader market, particularly in the short term. The overall market has shown resilience, while Clinitech's continued decline indicates specific issues affecting the company that are not reflected in the general market trends.